Monitor for any definitive agreement or announcement of a business combination target, as PMGC's stated purpose includes facilitating M&A opportunities. The retroactive effective date of the sponsor transfer suggests this structure was pre-arranged around the IPO; watch for any subsequent 13D amendments indicating active deal negotiations.
Price Chart
Executive Summary
PMGC Holdings Inc. filed a Schedule 13D disclosing beneficial ownership of 2,728,070 Class A ordinary shares of NorthStrive Acquisition Corp I (NSAI), representing 21.43% of the outstanding shares. PMGC became the sole member of the SPAC's sponsor, NorthStrive Sponsor I LLC, via an amended LLC agreement dated September 25, 2026, effective retroactively to April 24, 2026. The filing indicates PMGC may engage in discussions regarding potential strategic transactions, including M&A opportunities, but no definitive agreements exist.
Key Financial Metrics
Key Facts
- PMGC Holdings Inc. beneficially owns 2,728,070 Class A ordinary shares of NSAI, representing 21.43% of shares outstanding.
- The stake consists of 2,496,320 Class A shares underlying Class B ordinary shares (subject to forfeiture of up to 325,607 shares if over-allotment not exercised) and 231,750 Class A shares from a private placement.
- PMGC became the sole member of NorthStrive Sponsor I LLC via an amended LLC agreement dated September 25, 2026, effective retroactively to April 24, 2026.
- The filing states the Reporting Persons may engage in discussions concerning potential strategic transactions, including M&A, but no definitive agreements exist.
- PMGC is a diversified holding company (formerly Elevai Labs Inc.) with a principal office in Newport Beach, CA.
Financial Impact
PMGC acquired its membership interest in the sponsor for $1.00 total consideration. The stake represents 21.43% of NSAI's outstanding Class A ordinary shares.
Risk Factors
- No definitive business combination agreement is in place; the SPAC may fail to complete a deal within its timeline.
- Up to 325,607 Class B shares are subject to forfeiture if the underwriter's over-allotment option is not exercised, reducing effective ownership.
- PMGC's prior corporate history (formerly Elevai Labs Inc., a life sciences company) may not align with the SPAC's stated focus on energy & transportation.
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D Filing (Primary) | 0001213900-26-104805 |
| Document: ea030701501ex99-2.htm | 0001213900-26-104805 |
| Document: 0001213900-26-104805-index-headers.html | 0001213900-26-104805 |
| Document: 0001213900-26-104805-index.html | 0001213900-26-104805 |
| Document: 0001213900-26-104805.txt | 0001213900-26-104805 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 3d ago | SC 13D/A | $9.91 | awaiting T+20 | — | $9.90 (−0.15%) |
Sep 29, 2026 26d ago | SC 13D | $9.89 | awaiting T+20 | — | $9.90 (+0.05%) |
Aug 31, 2026 7w ago | 8-K | — | awaiting T+20 | — | — |
Aug 27, 2026 8w ago | 8-K | — | awaiting T+20 | — | — |
Aug 26, 2026 8w ago | 3 | — | awaiting T+20 | — | — |
Aug 26, 2026 8w ago | 3 | — | awaiting T+20 | — | — |
Aug 25, 2026 8w ago | 3 | — | awaiting T+20 | — | — |
Aug 19, 2026 9w ago | 424B4 | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers